Gentian Diagnostics ASA (OSL: GENT)
Norway flag Norway · Delayed Price · Currency is NOK
50.00
-2.50 (-4.76%)
Aug 30, 2024, 4:27 PM CET

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 38.26M NOK in the quarter ending June 30, 2024, with 5.81% growth. This brings the company's revenue in the last twelve months to 151.51M, up 22.63% year-over-year. In the year 2023, Gentian Diagnostics ASA had annual revenue of 142.35M with 27.18% growth.

Revenue (ttm)
151.51M
Revenue Growth
+22.63%
P/S Ratio
5.07
Revenue / Employee
2.61M
Employees
58
Market Cap
771.12M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023142.35M30.42M27.18%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 201955.38M9.56M20.87%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 533.17M
Nordhealth AS 471.77M
Nykode Therapeutics AS 69.44M
Photocure ASA 513.58M
Carasent ASA 254.01M
ArcticZymes Technologies ASA 117.80M
Hofseth BioCare ASA 230.08M
Navamedic ASA 543.49M
Revenue Rankings